This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: Amazon, AstraZeneca, CME, Cisco and General Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, AstraZeneca, CME, Cisco and General Electric
Will 737 Order Cancellations Further Dent Boeing's Prospects?
by Zacks Equity Research
For March and April, Boeing (BA) reports a total of 258 737 MAX aircraft cancellations, led by the pandemic's devastating impacts on global air travel.
Top Stock Reports for Amazon, AstraZeneca & CME Group
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com (AMZN), AstraZeneca (AZN) and CME Group (CME).
Can Industrial ETFs Gain Post Mixed Q1 Earnings?
by Sweta Jaiswal, FRM
We discuss the impact of Q1 earnings releases of some major players on industrial ETFs with heavy exposure to the same.
General Electric (GE) Announces Debt-Restructuring Actions
by Zacks Equity Research
General Electric (GE) commences tender offers for notes previously issued by it and its subsidiaries. Also, its GE Capital segment is considering private debt offerings.
The Zacks Analyst Blog Highlights: Merck, PayPal, Royal Dutch Shell, BlackRock and General Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, PayPal, Royal Dutch Shell, BlackRock and General Electric
Danaher (DHR) Beats Q1 Earnings Estimates, Provides Bleak View
by Zacks Equity Research
Danaher's (DHR) Q1 results reflect healthy growth in organic sales and the impacts of forex woes. Core sales in Q2 are expected to reflect the pandemic woes and gains from Cytiva.
Top Research Reports for Merck, PayPal & Royal Dutch Shell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), PayPal (PYPL) and Royal Dutch Shell (RDS.A).
Does Warren Buffett's Latest Move Spell Doom for Airline ETF?
by Sweta Jaiswal, FRM
The coronavirus outbreak has resulted in declining air travel plans and travel restrictions imposed by the government. Meanwhile, Buffett has bailed out his entire holdings in airlines industry.
Timing the Market, Is it Possible? - May 04, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Gilead's Coronavirus Drug Shows Positive Data
by Zacks Equity Research
Gilead's Coronavirus Drug Shows Positive Data
Positive Data for Gilead's (GILD) Remdesivir; Plus Q1 for BA, GE
by Mark Vickery
This is obviously remarkably good news for COVID-19 suffers, the general public in the throes of this pandemic, and of course Gilead itself.
General Electric (GE) Q1 Earnings Lag Estimates, View Gloomy
by Zacks Equity Research
General Electric's (GE) first-quarter 2020 earnings reflect the adverse impacts of the coronavirus outbreak. Persistence of the headwinds is likely to impact second-quarter results as well.
General Electric (GE) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
GE (GE) delivered earnings and revenue surprises of -16.67% and -0.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
General Electric (GE) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
General Electric's (GE) first-quarter 2020 results are expected to reflect the adverse impacts of the pandemic despite pent-up demand for a few products, healthy liquidity and deleveraging actions.
Equities See Modest Declines as Many Businesses Prepare to Reopen
by David Borun
A reduction in Coronavirus cases and public outcry have many states planning a resumption of business activities.
General Electric (GE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
General Electric (GE) closed at $6.42 in the latest trading session, marking a -0.93% move from the prior day.
Earnings Preview: General Electric (GE) Q1 Earnings Expected to Decline
by Zacks Equity Research
GE (GE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
General Electric (GE) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
General Electric (GE) closed at $6.48 in the latest trading session, marking a -0.46% move from the prior day.
Emerson (EMR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Emerson's (EMR) Q2 earnings are likely to have gained from solid key process and hybrid end markets despite weak global discrete manufacturing market and coronavirus-led issues.
Microsoft (MSFT) Partners GE Healthcare to Fight Coronavirus
by Zacks Equity Research
Microsoft (MSFT) inks deal with GE Healthcare to roll out patient monitoring software with an aim to limit COVID-19 exposure for medical staff and conserve PPEs.
Healthy Business to Aid Danaher in Q1 Despite Coronavirus Woes
by Zacks Equity Research
Danaher's (DHR) healthy businesses are likely to aid, driven by segmental performances in the first quarter of 2020. However, concerns related to the coronavirus outbreak persist.
The Zacks Analyst Blog Highlights: Boeing, General Electric, Raytheon Technologies, Rolls-Royce and Safran
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Boeing, General Electric, Raytheon Technologies, Rolls-Royce and Safran
General Electric (GE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
General Electric (GE) closed at $6.93 in the latest trading session, marking a -1.35% move from the prior day.
When Does Market Timing Actually Work? - April 14, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?